All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
- 2006 (1) Apply 2006 filter
- 2007 (2) Apply 2007 filter
- 2008 (2) Apply 2008 filter
- 2009 (2) Apply 2009 filter
- 2010 (1) Apply 2010 filter
- 2011 (3) Apply 2011 filter
- 2012 (3) Apply 2012 filter
- 2013 (2) Apply 2013 filter
- 2014 (1) Apply 2014 filter
- 2015 (3) Apply 2015 filter
- 2016 (2) Apply 2016 filter
- 2017 (1) Apply 2017 filter
- 2018 (2) Apply 2018 filter
- 2019 (1) Apply 2019 filter
- 2020 (1) Apply 2020 filter
- Good Clinical Practice (1) Apply Good Clinical Practice filter
- Health technology assessment (21) Apply Health technology assessment filter
- Methodology and databases (1) Apply Methodology and databases filter
- Organisation and financing of health care (HSR) (6) Apply Organisation and financing of health care (HSR) filter
- Biological and genetic diagnostic tests (2) Apply Biological and genetic diagnostic tests filter
- Cancer (2) Apply Cancer filter
- Cardiovascular Diseases (2) Apply Cardiovascular Diseases filter
- Drugs (9) Apply Drugs filter
- Ear, nose and throat (1) Apply Ear, nose and throat filter
- Endocrine diseases, diabetes and liver diseases (3) Apply Endocrine diseases, diabetes and liver diseases filter
- Geriatrics and chronic diseases (4) Apply Geriatrics and chronic diseases filter
- Gynaecology, pregnancy and delivery (1) Apply Gynaecology, pregnancy and delivery filter
- Infectious diseases (7) Apply Infectious diseases filter
- Musculoskeletal Diseases (3) Apply Musculoskeletal Diseases filter
- Neurology and brain disease (1) Apply Neurology and brain disease filter
- Pediatrics (3) Apply Pediatrics filter
- Prevention, Screening and vaccination (10) Apply Prevention, Screening and vaccination filter
- Respiratory diseases (2) Apply Respiratory diseases filter
-
[An evaluation procedure for the emerging medical technologies]
KCE Reports 44 (2006)
-
[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]
KCE Reports 157 (2011)
-
[Fatigue Syndrome: diagnosis, treatment and organisation of care]
KCE Reports 88 (2008)
-
[Hepatitis C: Screening and Prevention]
KCE Reports 173 (2012)
-
[Vaccine safety surveillance in Belgium : place and limits of a background rate approach]
KCE Reports 188 (2012)
-
A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study
KCE Reports 231 (2014)
-
Belgian guidelines for economic evaluations and budget impact analyses: second edition
KCE Reports 183 (2012)
-
Cervical and lumbar total disc replacements
KCE Reports 254 (2015)
-
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
KCE Reports 238 (2015)
-
Cost-effectiveness analysis of HPV vaccination of boys in Belgium
KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.
-
Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
KCE Reports 155 (2011)
-
Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study
KCE Reports 127 (2010)
-
Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C
KCE Reports 276 (2016)
-
How to improve the Belgian process for Managed Entry Agreements? An analysis of the Belgian and international experience
KCE Reports 288 (2017)
-
HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment
KCE Reports 64 (2007)
-
Novel serum biomarkers for the prediction of cardiovascular risk
KCE Reports 201 (2013)
-
Organisation of diagnosis and treatment of obstructive sleep apnoea syndrome: an international comparison
KCE Reports 330 (2020)
-
Percutaneous Vertebroplasty and Balloon Kyphoplasty
KCE Reports 255 (2015)
-
Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment
KCE Reports 111 (2009)
-
Responsible use of high-risk medical devices: the example of 3D printed medical devices
KCE Reports 297 (2018) 3D printing is generating increased interest in the medical sector, namely in orthopaedics and dentistry, but there is no evidence that 3D-printed implants are as effective or safe as “classical” products. Yet they can currently be used without restrictions by doctors, even when they are “at high risk” (that is, more often than not, implantable).